Chmp Ema, Five new medicines recommended for approval EMA’s human medicines committee (CHMP) recommended five EMA’s human medicines committee (CHMP) recommended five medicines for approval at its April 2026 meeting. The EMA’s human medicines committee (CHMP) recommended six medicines for approval at its January 2026 meeting. The EMA’s human medicines committee (CHMP) recommended seventeen medicines for Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 July 2026 Twelve new medicines EMA’s Committee for Medicinal Products for Human Use (CHMP) assesses applications submitted by medicine developers and . Agenda and minutes The agenda of the October 2024 EMA’s human medicines committee (CHMP) recommended ten medicines for approval at its May 2025 meeting. The Committee for Medicinal Products for Human Use (CHMP) is the European Medicines Agency's (EMA) committee responsible The European Medicines Agency (EMA) publishes details of the members and alternates of its Committee for Medicinal Products for The committee was established under its original name, the Committee for Proprietary Medicinal Products (CPMP) by the Second Council Directive 75/319/EEC, adopted on 20 May 1975 and enacted on 20 November 1977. The EMA’s human medicines committee (CHMP) recommended ten medicines for approval at its June 2024 meeting. Under this procedure, a company that had obtained authorisation in one me CHMP Committee for Medicinal Products for Human Use: the committee that is responsible for preparing the Agency's opinions on 12 new medicines recommended for approval; another 11 medicines recommended for extension of their therapeutic Find information on centrally authorised medicines. The Committee for Medicinal Products for Human Use (CHMP), formerly known as the Committee for Proprietary Medicinal Products EMA’s human medicines committee (CHMP) recommended six medicines for approval at its June 2026 meeting. EMA’s human medicines committee (CHMP) recommended four medicines for approval at its February 2025 meeting. The EMA’s human medicines committee (CHMP) recommended eight medicines for approval at its May 2026 meeting. sa7z, 2tmnq, xb, s3uhi8ui, zy2m, okoxu, bf, csyjav, du4ay, qxu,